ArticleEuropean heart journal open2026
Baseline right bundle branch block and clinical outcomes in patients undergoing transcatheter aortic valve implantation: a Danish nationwide cohort study.
Article in European heart journal open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: In the largest nationwide study of Danish patients undergoing transcatheter aortic valve implantation, we examined the clinical impact of pre-existing right bundle branch block - a known risk factor for permanent pacemaker implantation - on outcomes including pacemaker implantation, heart failure, and all-cause mortality. Methods and results: We included first-time transcatheter aortic valve implantation patients in Denmark from 2008 to 2021. Patients were stratified by baseline right bundle branch block status using the digital Danish Nationwide Electrocardiogram Cohort. The study outcomes were new pacemaker implantation, heart failure, and all-cause mortality at 30, 90, and 365 days. A composite of the study outcomes was also assessed. A total of 4900 patients were included, of whom 438 (9%) had baseline right bundle branch block. Mean age was 81 years, 55% were male. At 90 days, the overall pacemaker implantation incidence was 9%, but markedly higher in the right bundle branch block group: 28.3% vs. 7.1% [hazard ratio (HR) 4.61, 95% confidence interval (CI) 3.60-5.91]. Right bundle branch block was not associated with higher rates of heart failure (10.1% vs. 8.3%; HR 1.23, 95% CI 0.86-1.77) or death (3.7% vs. 3.6%; HR 1.08, 95% CI 0.64-1.82). The findings were consistent at 1 year. Conclusion: In this comprehensive nationwide cohort, right bundle branch block strongly predicted pacemaker implantation after transcatheter aortic valve implantation but importantly, not heart failure or all-cause mortality. The neutral association with heart failure and mortality should be explored further.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.